Aarti Pharmalabs Share Price

Aarti Pharmalabs Limited was initially incorporated as Aarti Organics Limited in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anticancer, AntiAsthma, AntiHypertensive etc.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.In 202122, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.The RD centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semicommercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024.

Aarti Pharmalabs reported a Q2 FY 2025-26 revenue of ₹418.33 crore, up 14.4% YoY, with net profit increased 25.6% to ₹28.57 crore. For the full year FY2025–2026, revenue reached ₹2125.19 crore and profit touched at ₹272.4 crore. As of Sep '25, Aarti Pharmalabs’s market capitalisation stood at ₹6,711.98 crores. Shareholding as of Sep '25 shows promoters holding 42.9%, with FIIs at 8%, DIIs at 7%, and public at 42.1%.

As of 13 Dec 2025, Aarti Pharmalabs share price is ₹740.4. The stock opened at ₹747.8 and had closed at ₹747.9 the previous day. During today’s trading session, Aarti Pharmalabs share price moved between ₹734.05 and ₹748.00, with an average price for the day of ₹741.02. Over the last 52 weeks, the stock has recorded a low of ₹557.05 and a high of ₹971.00. In terms of performance, Aarti Pharmalabs share price has declined by 19.4% over the past six months and has increased by 24.32% over the last year.